Short Ideas - Telik, Inc. (NASDAQ:TELK) announced last Friday that the FDA granted its lead candidate, ezatiostat HCL (Telintra), orphan drug designation for the treatment of myelodysplastic syndrome … Continue Reading
Read NowMost Popular - Synageva (NASDAQ:GEVA) announced its third stock offering in twelve months on Thursday, which after a pricing update, should raise approximately $90M for pipeline development, particularly … Continue Reading
Read NowLong Ideas - Happy Holidays from the team at PropThink! Our report on Trius Therapeutics tackled the short thesis, repudiating the focal points of the bear argument. Shares are, … Continue Reading
Read NowShort Ideas - Quarterly results for Amedisys Inc. (NASDAQ:AMED) were exceptionally poor as we reported on Tuesday (here), and the follow through from analysts Wednesday morning is highly … Continue Reading
Read NowShort Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) are off 25% as partner Pfizer (NYSE:PFE) noted Thursday on its earnings call that Remoxy, PTIE’s lead product, is a … Continue Reading
Read NowQuick Picks - United Therapeutics Corporation (NADSAQ:UTHR) announced after hours on Tuesday that it’s application for an oral formulation of Remodulin (treprostinil) received a Complete Response Letter (CRL) from the … Continue Reading
Read NowShort Ideas - Puma Biotechnology (NYSE:PBYI) uplisted to the New York Stock Exchange from the OTC Bulletin Board on Friday, generating significant trading interest in the stock and a 40% … Continue Reading
Read Now